TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03042429

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cycles N8, N5 and N6
Description: two chemotherapy cycles N8 followed by standard arm therapy

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cycles N5 and N6
Description: Standard arm six chemotherapy cycles (3xN5 and 3x N6) followed by myeloablative therapy with stem cell support and isotretinoin
Study: NCT02816268

Intervention type: OTHER
Group type: OTHER
Intervention: Pulmonary vein isolation

Intervention type: OTHER
Group type: OTHER
Intervention: Pulmonary vein isolation
Study: NCT03349138

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Glove

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Robotic Glove

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electrical Stimulation
Study: NCT03877614

Intervention type: OTHER
Intervention: ASCVD risk score
Description: ASCVD score\< 10% will be in the control or low-risk group

Intervention type: OTHER
Intervention: ASCVD risk score
Description: ASCVD score\< 10% will be in the control or low-risk group
Study: NCT00543270

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Powerlink infrarenal bifurcated stent graft delivery system
Description: Endovascular abdominal aortic aneurysm repair
Study: NCT02159365

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Study: NCT00543270

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open Surgery
Description: Open surgical abdominal aortic aneurysm repair
Study: NCT01652053

Intervention type: DEVICE
Intervention: Disc Nucleus Replacement (InterCushion DNP)
Description: The device is intended for spinal arthroplasty in skeletally mature patients with leg pain due to a herniated disc with or without back pain, who are having a discectomy at one level from L2 -S1. These patients should have no spondylolisthesis at the involved level.
Study: NCT04236050

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rocuronium
Description: Rocuronium administered in continuous infusion or multiple bolus doses

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rocuronium
Description: Rocuronium administered in continuous infusion or multiple bolus doses
Study: NCT04437550

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: high intensity exercise = 15 x 60 s sprints at 85% velocity of VO2max (vVO2max) with 60 s walking at 20% vVO2max or moderate intensity exercise = walking at 60% vVO2max
Study: NCT00089154

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study: NCT02774525

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reinforcement for drug & alcohol abstinence

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reinforcement for drug & alcohol abstinence

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parenting intervention

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting
Study: NCT02774525

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (TAU)
Description: Outpatient substance-abuse therapy plus drug \& alcohol screening plus support for personal goal setting
Study: NCT00796549

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BiBW 2992
Description: BIBW 2992 in EGFR FISH positive NSCLC patients
Study: NCT01102946

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab
Description: Ranibizumab (Lucentis), intravitreal injections of 0.05ml

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Panretinal Photocoagulation
Description: Panretinal photocoagulation with green laser according to ETDRS

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Panretinal Photocoagulation
Description: Panretinal photocoagulation with green laser according to ETDRS
Study: NCT02661256

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NCPAP
Description: Does NCPAP induce dysphagia in neonates? Each baby will be evaluated for dysphagia (using fluoroscopy) while on NCPAP and off NCPAP.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: NCPAP
Description: Does NCPAP induce dysphagia in neonates? Each baby will be evaluated for dysphagia (using fluoroscopy) while on NCPAP and off NCPAP.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Varibar® Thin Liquid Barium Sulfate for Suspension
Description: Liquid barium is used as a contrast material to allow visualization of swallowed boluses under fluoroscopy.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Varibar® Thin Liquid Barium Sulfate for Suspension
Description: Liquid barium is used as a contrast material to allow visualization of swallowed boluses under fluoroscopy.
Study: NCT04143490

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: 60 minutes of continuous exercise at 65% VO2peak and drink ingestion

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 60 minutes of continuous exercise at 65% VO2peak and drink ingestion
Study: NCT05877937

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supportive care (Watching a comedy movie)
Description: A 10.1 inch Android tablet (2 pieces) and disposable earplugs for each patient were used in the study. A comic film archive was created in line with the recommendation and consultancy of department of state conservatory and performing arts. In this regard, the officials of the Conservatory stated that they had no standardized comedy films specific to society and emphasized that the standardization of art limits art activities. Therefore, there should be no limitations for art. In the film archive cre-ated according to their suggestions, there were a total of five comedy movies, including three Turkish comedies, one foreign romantic comedy, and one foreign Turkish-dubbed family comedy. The original/licensed versions of the movies in this archive were ob-tained and uploaded to the tablet. The movies lasted 90-120 minutes (as long as the av-erage duration of IV treatment). The patients selected the movie that they would watch during the treatment.
Study: NCT01949571

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirtazapine (REMERON, Schering-Plough-Organon)
Description: During the first and second phase of the study,the mirtazapine group received 30 mg of mirtazapine daily. During the third phase, the mirtazapine group received 15 mg of mirtazapine.
Study: NCT01159678

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: online psychoeducation
Description: The online psychoeducation contains 12 modules which will be administered once per week over the course of three months. The content of each module is as follows:~1. Important of sexuality to quality of life. \& Definitions of sexual desire and arousal.~2. Consideration of the predisposing, precipitating, and perpetuating factors in his/her sexual difficulties.~3. Sexual beliefs.~4. Mindfulness.~5. Genital anatomy and physiology.~6. Body Image.~7. Relationship satisfaction and communication.~8. Body-oriented mindfulness exercises (focusing and self-observation).~9. Using Thought records.~10. Mindfulness and the thought stream.~11. Sexual aids to boost arousal.~12. Moving on.~In addition to these weekly modules, all participants will have access to a moderated and password-protected bulletin board to which participants can post questions and the PI will respond.
Study: NCT02597452

Intervention type: DEVICE
Group type: OTHER
Intervention: intelligent Breast Exam, iBE
Description: A bilateral iBE exam will be performed on the entire breast in addition to a clinical breast exam administered by a trained individual. If the patient is selected to participate in the inter-rater reliability portion of the study, the subject will undergo both the iBE and the clinical breast exams twice sequentially performed by two different separately trained individuals during the same visit.
Study: NCT01555970

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC)
Description: Week 1: 1200 mg (one 600 mg capsule twice a day) Week 2: 2400 mg (two 600 mg capsules twice a day) Weeks 3-16: 3000 mg (two 600 mg capsules in the morning and 3 in the evening)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Week 1: one capsule twice a day Week 2: two capsules twice a day Weeks 3-16: two capsules in the morning and 3 in the evening
Study: NCT02400606

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Constructing VP cases
Description: The participants were presented with a short case overview. The control group solved the cases, whereas the intervention group also received the final diagnosis and had to complete the history, physical findings, and lab results. After a week, participants completed a transfer test involving two standardized patients presenting a respiratory case and a cardiology case, respectively. Performances were video-recorded and subsequently assessed by two blinded raters using the Reporter-Interpreter- Manager-Educator (RIME) framework. Knowledge gains were assessed using a pre- and post-test of a 95-item Multiple-Response-Questionnaire (MRQ).

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Solving VP cases
Description: See above
Study: NCT02052115

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: 12 month exercise and weight loss intervention
Study: NCT01010490

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Torsional ultrasound (INFINITI, Alcon, USA)
Description: Comparison of inta-operative efficacy and safety
Study: NCT04511091

Intervention type: PROCEDURE
Intervention: VATS lobectomy
Description: VATS lobectomy allows surgeons to carry out exactly the same operation within the chest that is performed by thoracotomy, but it is done through 3-4 small incisions without rib spreading rather than the large incision with rib spreading that a thoracotomy entails. The surgeon gains his view inside the chest from a small video camera inserted through one of the small incisions, and the procedure is carried out with long instruments passed through the other small incisions.
Study: NCT01522196

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Varespladib
Description: 48 hour continuous infusion delivered intravenously (IV)at a rate of 110µg/kg/hr.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (Normal Saline)
Description: 48 hour continuous infusion delivered intravenously (IV)at a rate of 110µg/kg/hr.
Study: NCT02415829

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine plus oxaliplatin
Description: The neoadjuvant chemotherapy consisted of oxaliplatin, 130 mg/m² on day 1, with capecitabine, 1000 mg/m² twice daily for 14 days every 3 weeks (the XELOX regimen)
Study: NCT02737371

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F901318 Dose level A oral
Description: Adverse events days 1-10

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo dose level A oral
Description: Placebo adverse events days 1-10
Study: NCT00248911

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness based meditation program
Description: Subjects will participate in an intervention consisting of group and individual instruction in a meditation-based practice of stress-reduction and cognitive-affective-behavioral learning.
Study: NCT01912443

Intervention type: DRUG
Intervention: bevacizumab
Description: 5 mg/Kg, IV (in the vein) on day 1 and day 14 of each 28 day cycle. Number of Cycles: until progression.
Study: NCT02264379

Intervention type: RADIATION
Intervention: normal fractionated irradiation
Description: 25\*2 Gy (once a day, 5 days a week)

Intervention type: RADIATION
Intervention: hypo fractionated irradiation
Description: 3\*10 Gy (once a day, 2-3 days a week)
Study: NCT01010490

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Longitudinal U/S (Infiniti system, Alcon, USA)
Description: comparison of efficacy and safety

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Longitudinal U/S (LEGACY 20000, Alcon, USA)
Description: Interrupted energy modality
Study: NCT02221635

Intervention type: PROCEDURE
Intervention: rTMS + risperidone
Description: Intensity of 120% of individually determined motor threshold; frequency : 1 Hz; 360 impulsions; on period : 1 min; off period : 30 s.5 sessions per week for 4-6 weeks,than 2 sessions per week for 2 months, repeat that for 12 months. Meanwhile,risperidone (2-4 mg) was took orally.

Intervention type: DRUG
Intervention: Risperidone
Description: Risperidone (2-4 mg) was took orally.
Study: NCT06659484

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment
Description: Evaluation carried out during a day hospital at T0 (initial assessment) and T3 (after the exercise program at around 3 months) including:~1. Clinical assessment by a geriatrician~   * Medical history; systematic search for symptomatic elements (asthenia, anorexia, weight loss); research into antecedents (chronic pathologies, etc.), treatments, lifestyle, eating habits, sedentary lifestyle,~  * Complete clinical examination: particularly of the musculoskeletal system, morphological data (weight and height, calf circumference), analysis of risk of falls,~  * Current medical treatments~  * Autonomy for basic activities (ADL), instrumental activities of daily living (IADL), visual disorders, hearing impairment, etc.~  * Assessment of comorbidities (Charlson score)~  * Screening for sarcopenia (using the SARC-F questionnaire),~  * An inventory of falls and their traumatic consequences,~  * Assessment of frailty status using FRIED criteria,~2. Nutritional assessment :~   * nutritional status will also be asses

Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment
Description: Evaluation carried out during a day hospital at T0 (initial assessment) and T3 (after the exercise program at around 3 months) including:~1. Clinical assessment by a geriatrician~   * Medical history; systematic search for symptomatic elements (asthenia, anorexia, weight loss); research into antecedents (chronic pathologies, etc.), treatments, lifestyle, eating habits, sedentary lifestyle,~  * Complete clinical examination: particularly of the musculoskeletal system, morphological data (weight and height, calf circumference), analysis of risk of falls,~  * Current medical treatments~  * Autonomy for basic activities (ADL), instrumental activities of daily living (IADL), visual disorders, hearing impairment, etc.~  * Assessment of comorbidities (Charlson score)~  * Screening for sarcopenia (using the SARC-F questionnaire),~  * An inventory of falls and their traumatic consequences,~  * Assessment of frailty status using FRIED criteria,~2. Nutritional assessment :~   * nutritional status will also be asses
Study: NCT00096070

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: Undergo radiation therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: oxaliplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluorouracil
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Description: Given IV
Study: NCT06659484

Intervention type: OTHER
Intervention: Multicomponent exercise program
Description: After inclusion in the protocol, participants with mobility disability risk factors are assigned to specialized and experienced kinesiologists at the end of the medical consultation.~Patients will be invited to take part in group-based exercise sessions, in small groups of no more than 10 patients, under the supervision of a kinesiologist. There will be 20 sessions over 10 weeks, at a rate of 2 sessions per week, each lasting one hour. The Multicomponent exercise program included progressive resistance and balance training.
Study: NCT04068714

Intervention type: PROCEDURE
Intervention: Type of aneurysm repair
Description: In open surgery repair group, aneurysm repair was performed by open surgery including aortobifemoral bypass, aorto-bi-iliac bypass and tubular aortic bypass. In endovascular repair (EVAR group), aneurysm correction was performed by percutaneous approach, femoral cutdowns and aorto-uni-iliac EVARs with femorofemoral bypass.

Intervention type: PROCEDURE
Intervention: Type of aneurysm repair
Description: In open surgery repair group, aneurysm repair was performed by open surgery including aortobifemoral bypass, aorto-bi-iliac bypass and tubular aortic bypass. In endovascular repair (EVAR group), aneurysm correction was performed by percutaneous approach, femoral cutdowns and aorto-uni-iliac EVARs with femorofemoral bypass.
Study: NCT02559921

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rhRIG（20 IU/kg）

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rhRIG（40 IU/kg）
Study: NCT02737371

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F901318 Dose level B oral
Description: F901318 adverse events days 1-10

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo dose level B oral
Description: Placebo adverse events days 1-10

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F901318 Dose level C oral
Description: F901318 adverse events days 1-10

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Dose level C oral
Description: Placebo adverse events days 1-10
Study: NCT00376675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylphenidate hydrochloride
Description: Given orally

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Given orally
Study: NCT02744781

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Lumbar disc degeneration; LDD
Description: All MR images, taken at 5 lumbar intervertebral disc levels from the first lumbar (L1) vertebra to the first sacral vertebra (S1), were independently evaluated by 2 experienced orthopedic specialists in a random order using a grading system for LDD assessment. Using a comprehensive grading system for LDD, discs were classified into 5 grades, as described by Pfirrman et al. This system uses characteristics of disc structure, distinction between the nucleus and annulus, MRI signal intensity, and intervertebral disc height for grading, and has been accepted as a standardized and reliable evaluation tool for assessment of MRI disc morphology.
Study: NCT00596895

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Isoflavone
Description: Ingested 47 mg of isoflavone in three 8 oz servings per day
Study: NCT03209791

Intervention type: OTHER
Intervention: Biopsies
Description: Biopsy will be done on the Vastus Lateralis muscle in all groups

Intervention type: OTHER
Intervention: Biopsies
Description: Biopsy will be done on the Vastus Lateralis muscle in all groups

Intervention type: OTHER
Intervention: Biopsies
Description: Biopsy will be done on the Vastus Lateralis muscle in all groups

Intervention type: OTHER
Intervention: Biopsies
Description: Biopsy will be done on the Vastus Lateralis muscle in all groups
Study: NCT00951119

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Resperate
Description: device-guided breathing exercises

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Resperate
Description: breathing device without slowing of breathing frequency
Study: NCT00954824

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Endotoxin (LPS)
Description: Single administration low-dose (3 ng/kg) endotoxin (LPS).
Study: NCT03865849

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cooled radiofrequent treatment
Description: In the cooled radiofrequency group a treatment of 60°C measured at the tip and on average 80°C in the targeted tissue is applied during 150 seconds using the Coolief system.
Study: NCT06659484

Intervention type: OTHER
Intervention: Follow-up at T3 + 6 months and T3 + 12 months
Description: Follow-up at T3 + 6 months :~- After the T3 visit, patients will either be redirected to independent practice (booklet) or to relay structures. At T3 + 6 months (6 months after the 3-month visit), the kinesiologists will call each patient to assess their compliance with the program, any difficulties encountered, any falls (and their severity and consequences), fear of falling, their level of ADL/IADL autonomy, level of PA practice (RAPA), presence of frailty appreciation (FRIED), whether or not they have entered an institution.~Follow-up at T3 + 12 months :~At T3+12 months (12 months after the 3-month visit), patients will be seen again by the kinesiologists to make a final assessment of their physical and functional conditions, with measurements (Handgrip, SPPB, TUG, gait parameters, leg strength) and questionnaires (SarQol and FES-I).~Patients will only be seen again by the kinesilogists, as this is mainly a check-up and final advice visit, to continue the exercises performed since.
Study: NCT03865849

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional radiofrequent treatment
Description: In the conventional radiofrequency group a treatment of 80°C at the tip is applied during 90 seconds at each nerve.
Study: NCT02052908

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen
Description: Given PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Naproxen
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo Administration
Description: Given PO

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Administration
Description: Given PO